摘要
Over the past decades, epidemiological evidence has documented risk factors of coronary artery disease (CAD), leading to extraordinary progress in understanding, preventing, and treating CAD. Nevertheless, CAD remains the top cause of mortality worldwide. The residual cardiovascular risk beyond these established factors has motivated the discovery of novel targets for risk reduction and effective treatment.
作者
戴宇翔
孙仲汉
郑琰
葛均波
Yuxiang Dai;Zhonghan Sun;Yan Zheng;Junbo Ge(Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Shanghai Institute of Cardiovascular Disease,Shanghai 200032,China;State Key Laboratory of Genetic Engineering,School of Life Sciences and Human Phenome Institute,Fudan University,Shanghai 200438,China)
基金
supported by the National Key R&D Program of China (2021YFC2500500)
the National Natural Science Foundation of China (81973032)
the Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR1007A)
the Program of Shanghai Academic Research Leader (22XD1423300)。
